Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116514 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Wen-Chung Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Health Industry Technology, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan …. Hauptthemen laut MEDLINE: Oxidative Stress, Asthma, Stilbenes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council, Chang Gung University.
Abstract (Originalsprache)
Gnetum cleistostachyum has been used in traditional Chinese medicine to treat arthritis and bronchitis. Isorhapontigenin, a naturally occurring stilbenoid structurally related to resveratrol, is isolated from G. cleistostachyum and has been reported to exhibit anti-inflammatory and antioxidant properties. Here, we examined whether isorhapontigenin can ameliorate airway inflammation, oxidative stress, and airway hyperresponsiveness (AHR) in an ovalbumin (OVA)-induced mouse model of allergic asthma. Female BALB/c mice were sensitized and challenged with OVA and subsequently administered isorhapontigenin. Lung function and AHR were evaluated, along with histopathological alterations. Inflammatory profiles and oxidative stress-associated indices were determined using bronchoalveolar lavage fluid (BALF) and lung tissues. Complementary in vitro studies were conducted in human bronchial epithelial BEAS-2B cells to assess cytokine-related responses, intracellular reactive oxygen species (ROS) generation, and monocyte-epithelial adhesion. Isorhapontigenin treatment markedly improved AHR and mitigated airway pathology in asthmatic mice, including inflammatory cell influx, mucus-producing goblet cell expansion, and airway remodeling features such as collagen accumulation. Consistently, BALF analysis showed reduced Th2-associated cytokines, eotaxins, and other pro-inflammatory mediators. Isorhapontigenin also alleviated oxidative stress-related disturbances and was associated with improved inflammatory status in lung tissues. In BEAS-2B cells, isorhapontigenin suppressed the expression of eotaxins, intercellular adhesion molecule-1, and pro-inflammatory cytokines, accompanied by decreased ROS production and reduced monocyte adhesion. These data indicate that isorhapontigenin attenuates key asthma phenotypes by concurrently dampening inflammatory responses and oxidative stress. Isorhapontigenin may therefore represent a promising candidate for the development of adjunctive strategies for asthma management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Health Industry Technology, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan City, Taiwan; Department of Traditional Chinese Medicine, Chang Gung M…
- Department of Nutrition and Health Sciences, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan City, Taiwan; Aesthetic Medical Center, Department of Dermatology, Chang Gu…
- Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan City, Taiwan; Department of Nursing, Division of Basic Medical Sciences, Center for Drug Research and Development, Chang Gung University…
Förderung
- Chang Gung Memorial Hospital
- National Science and Technology Council
- Chang Gung University
Zitieren
APA
Huang, W. C., Wu, S. J., Cheng, S. C., Huang, T. H., & Liou, C. J. (2026). Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116514
Vancouver
Huang WC, Wu SJ, Cheng SC, Huang TH, Liou CJ. Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116514
BibTeX
@article{Huang2026,
author = {Huang, Wen-Chung and Wu, Shu-Ju and Cheng, Shu-Chen and Huang, Tse-Hung and Liou, Chian-Jiun},
title = {Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116514}
}
EUVIMED